These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 13676632)

  • 1. [Problem of an increase of strophanthin effect by cocarboxylase].
    MICHEL D; HARTLEB O
    Z Kreislaufforsch; 1959 Jun; 48(11-12):557-70. PubMed ID: 13676632
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of cocarboxylase on acute and chronic heart disease].
    BOSSI L; CAFFARRI F
    G Clin Med; 1955 Jan; 36(1):74-88. PubMed ID: 14391620
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of cocarboxylase and pyridoxol (vitamin B6) in large doses on certain heart diseases connected with stress].
    CELICE J; PLAS F; DUCHESNAY G; LEMONNIER F
    Therapie; 1957; 12(4):569-77. PubMed ID: 13467833
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ambulant treatment of relative cardiac insufficiency with strophil and berolase].
    HOYER H
    Med Monatsschr; 1958 Apr; 12(4):243-5. PubMed ID: 13551857
    [No Abstract]   [Full Text] [Related]  

  • 5. [Influence of age on the effect of strophanthin in man].
    MICHEL D; HARTLEB O; MARXHAUSEN E
    Z Klin Med; 1958; 155(3):288-309. PubMed ID: 13604588
    [No Abstract]   [Full Text] [Related]  

  • 6. [Intravenous strophanthin therapy in heart diseases and its importance in general practice].
    ASCHENBRENNER R
    Dtsch Med Wochenschr; 1956 Dec; 81(50):1988-91. PubMed ID: 13397271
    [No Abstract]   [Full Text] [Related]  

  • 7. [Considerations on the treatment of heart diseases; cocarboxylases].
    MARTELLI A
    Folia Cardiol; 1952 Dec; 11(6):519-31. PubMed ID: 13010283
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of enzymatic factors in various myocardial diseases].
    CECCHETTI G; DIOGUARDI N; PARENTI B
    Minerva Med; 1956 Jul; 47(56):179-83. PubMed ID: 13369252
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical use of strophanthin in the form of strophil].
    HAGGENMILLER W; GESCHKE HJ
    Munch Med Wochenschr; 1959 May; 101(19):848-51. PubMed ID: 13666753
    [No Abstract]   [Full Text] [Related]  

  • 10. [Critical remarks on intravenous strophanthin therapy].
    MULLER R; SCHILD W
    Arztl Wochensch; 1956 Nov; 11(46):1010-3. PubMed ID: 13394460
    [No Abstract]   [Full Text] [Related]  

  • 11. [The influence of cocarboxylase on the EKG changes in experimental strophanthin intoxication].
    BENDA L; DONEFF D; MOSER K
    Z Kreislaufforsch; 1959 Aug; 48():777-81. PubMed ID: 13798744
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cocarboxylase in the treatment of various heart diseases in children].
    Tam LJ; Tiernowa TI
    Pediatr Pol; 1971 Jun; 46(6):695-702. PubMed ID: 5570511
    [No Abstract]   [Full Text] [Related]  

  • 13. [Miroton as adjuvant for the performance of ambulant strophanthin therapy after dismissal from the hospital & restored compensation].
    ANGSTER H
    Medizinische; 1958 Jan; 2(2):90-2. PubMed ID: 13516220
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical studies on crataegutt-strophanthin & crataegutt].
    IMMICH H
    Dtsch Med J; 1959 Jan; 10(2):39-42. PubMed ID: 13639731
    [No Abstract]   [Full Text] [Related]  

  • 15. [The indication of use of pandigal and strophanthin mixed injection].
    STEINBERG H
    Med Klin; 1954 Jun; 49(23):927-8. PubMed ID: 13164985
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical experiences with the combination preparation crataegutt-strophanthin].
    SCHROER W
    Med Monatsschr; 1958 May; 12(5):312-4. PubMed ID: 13551873
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of cocarboxylase on metabolism in acute strophanthin poisoning in the dog].
    BENDA L; MOSER K
    Z Kreislaufforsch; 1960 Feb; 49():97-104. PubMed ID: 13798746
    [No Abstract]   [Full Text] [Related]  

  • 18. [Theoretical-experimental and clinical fundamentals of peroral strophanthin therapy].
    WIESEND W
    Ther Umsch; 1956 Sep; 13(9):172-6. PubMed ID: 13380794
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative efficiency of strophanthin preparations in cardiac disease.
    GOTTSEGEN G
    Ther Hung; 1954; 3():15-8. PubMed ID: 13247268
    [No Abstract]   [Full Text] [Related]  

  • 20. [Quantitative aspects of strophanthin activity].
    STORZ H
    Klin Wochenschr; 1958 Feb; 36(3):124-7. PubMed ID: 13540133
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.